-transparent.png){kind=logo}
ACC-9653, a prodrug of phenytoin synthesized to be water soluble, is converted to phenytoin by phosphatases. In this study, 43 patients received ACC-9653 IV or IM. Side effects were transient and minor. The conversion half-lives of ACC-9653 after intravenous and intramuscular administration averaged 8.4 and 32.7 minutes, respectively. Peak phenytoin concentrations occurred 42 minutes after IV and 151 minutes after IM administration.
Related Publications
I E Leppik, and
B A Boucher, and
B J Wilder, and
V S Murthy, and
C Watridge, and
N M Graves, and
R J Rangel, and
C A Rask, and
P Turlapaty
October 2005,
Journal of veterinary pharmacology and therapeutics,
I E Leppik, and
B A Boucher, and
B J Wilder, and
V S Murthy, and
C Watridge, and
N M Graves, and
R J Rangel, and
C A Rask, and
P Turlapaty
November 2006,
Annals of emergency medicine,
I E Leppik, and
B A Boucher, and
B J Wilder, and
V S Murthy, and
C Watridge, and
N M Graves, and
R J Rangel, and
C A Rask, and
P Turlapaty
December 2005,
Journal of veterinary pharmacology and therapeutics,
I E Leppik, and
B A Boucher, and
B J Wilder, and
V S Murthy, and
C Watridge, and
N M Graves, and
R J Rangel, and
C A Rask, and
P Turlapaty
November 1989,
Journal of pharmaceutical sciences,
I E Leppik, and
B A Boucher, and
B J Wilder, and
V S Murthy, and
C Watridge, and
N M Graves, and
R J Rangel, and
C A Rask, and
P Turlapaty
April 2007,
Journal of veterinary pharmacology and therapeutics,
I E Leppik, and
B A Boucher, and
B J Wilder, and
V S Murthy, and
C Watridge, and
N M Graves, and
R J Rangel, and
C A Rask, and
P Turlapaty
January 1996,
European journal of drug metabolism and pharmacokinetics,
I E Leppik, and
B A Boucher, and
B J Wilder, and
V S Murthy, and
C Watridge, and
N M Graves, and
R J Rangel, and
C A Rask, and
P Turlapaty
March 1988,
Journal of veterinary pharmacology and therapeutics,
I E Leppik, and
B A Boucher, and
B J Wilder, and
V S Murthy, and
C Watridge, and
N M Graves, and
R J Rangel, and
C A Rask, and
P Turlapaty
November 1988,
Journal of clinical pharmacology,
I E Leppik, and
B A Boucher, and
B J Wilder, and
V S Murthy, and
C Watridge, and
N M Graves, and
R J Rangel, and
C A Rask, and
P Turlapaty
June 1990,
British journal of anaesthesia,
I E Leppik, and
B A Boucher, and
B J Wilder, and
V S Murthy, and
C Watridge, and
N M Graves, and
R J Rangel, and
C A Rask, and
P Turlapaty
January 1984,
Journal of interferon research,
